We dont just help patients lose weight we help them lose dangerous visceral fat, preserve muscle, reduce medications, and improve long-term health
The STEP clinical trial program demonstrated semaglutide-treated patients achieved 1017 percent body weight reduction over 68 weeks, compared to 23 percent with placebo
(2011) identified a likely explanation for the observed activity, namely, the capacity to augment synaptic connectivity through the induction of new functional synapses
Our commitment to our Naperville patients is to deliver exceptional care through board-certified obesity specialists, all at affordable and transparent prices
If you're someone who likes to wait for the newest and most cutting-edge options, and you're okay waiting a bit longer, Retatrutide may be worth keeping an eye on
Phase 2 trial data showed a mean body weight reduction of approximately 24% at the 12 mg weekly maintenance dose over 48 weeks